Clinical Trials Logo

Diabetic Maculopathy clinical trials

View clinical trials related to Diabetic Maculopathy.

Filter by:
  • Not yet recruiting  
  • Page 1

NCT ID: NCT04699864 Not yet recruiting - Clinical trials for Diabetic Retinopathy

Evaluation of NeoRetina Artificial Intelligence Algorithm for the Screening of Diabetic Retinopathy at the CHUM

DR-NeoRetina
Start date: April 2024
Phase: N/A
Study type: Interventional

This prospective study aims to validate if NeoRetina, an artificial intelligence algorithm developped by DIAGNOS Inc. and trained to automatically detect the presence of diabetic retinopathy (DR) by the analysis of macula centered eye fundus photographies, can detect this disease and grade its severity.